These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23249424)

  • 1. Design, development and in vitro-in vivo study of tramadol-paracetamol inlay tablets.
    Kotta S; Bijumol C; Anitha Y; Dileep KJ; Valsala K
    Pharm Dev Technol; 2014 Feb; 19(1):1-9. PubMed ID: 23249424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of the pharmacokinetics of a sustained-release formulation of a tramadol/acetaminophen combination in healthy subjects.
    Im YJ; Jeon JY; Kim EY; Kim Y; Oh DJ; Yoo JS; Shin DH; Chae SW; Kim MG
    Clin Ther; 2015 Feb; 37(2):376-89. PubMed ID: 25618318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.
    Kumar P; Singh S; Mishra B
    Acta Pharm; 2009 Mar; 59(1):15-30. PubMed ID: 19304555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteers.
    Yi S; Chung YJ; Kim TE; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Jun; 33(6):728-37. PubMed ID: 21704237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and in vitro-in vivo relationship of controlled-release microparticles loaded with tramadol hydrochloride.
    Naeem Aamir M; Ahmad M; Akhtar N; Murtaza G; Khan SA; Shahiq-uz-Zaman ; Nokhodchi A
    Int J Pharm; 2011 Apr; 407(1-2):38-43. PubMed ID: 21241789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs].
    Li CJ; Yu YL; Yang QM; Li Y; Zhang YH; Wang JY
    Yao Xue Xue Bao; 2010 Sep; 45(9):1170-6. PubMed ID: 21351575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R; Kim YI; Chang SW; Kim JO
    Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of new formulation and its evaluation by capillary electrophoresis of tablets containing tramadol hydrochloride and paracetamol.
    Ciurba A; Hancu G; Cojocea LM; Sipos E; Todoran N
    Pharm Dev Technol; 2014 Nov; 19(7):833-8. PubMed ID: 24028179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of processing variables on the mechanical and release properties of tramadol matrix tablets incorporating Cissus populnea gum as controlled release excipient.
    Adeleye OA; Femi-Oyewo MN; Odeniyi MA
    Polim Med; 2014; 44(4):209-20. PubMed ID: 25932902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M; Berggren AC
    Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of bi-layer matrix tablets of tramadol hydrochloride: Comparison of rate retarding ability of the incorporated hydrophilic polymers.
    Arif H; Al-Masum A; Sharmin F; Reza S; Sm Islam SA
    Pak J Pharm Sci; 2015 May; 28(3):855-61. PubMed ID: 26004717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tablets compressed with gastric floating pellets coated with acrylic resin for gastro retention and sustained release of famotidine: in-vitro and in-vivo study.
    Qi X; Jiang Y; Zhang H; Wu Z
    J Pharm Pharmacol; 2015 Apr; 67(4):493-500. PubMed ID: 25495700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of oral suspensions of microparticles of ethylcellulose with tramadol.
    Morales ME; Ruiz MA; López G; Gallardo V
    Drug Dev Ind Pharm; 2010 Aug; 36(8):885-92. PubMed ID: 20184418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation Development and Optimization of Matrix Tablet of Tramadol Hydrochloride.
    Deb P; Singha J; Chanda I; Chakraborty P
    Recent Pat Drug Deliv Formul; 2017; 11(1):19-27. PubMed ID: 27712568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopharmaceutical evaluation of new slow release tablets obtained by hot tableting of coated pellets with tramadol hydrochloride.
    Szkutnik-Fiedler D; Sawicki W; Balcerkiewicz M; Mazgalski J; Grabowski T; Grześkowiak E
    Acta Pol Pharm; 2014; 71(5):813-20. PubMed ID: 25362810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of experiment approach for formulating multi-unit colon-targeted drug delivery system: in vitro and in vivo studies.
    Shah N; Sharma OP; Mehta T; Amin A
    Drug Dev Ind Pharm; 2016; 42(5):825-35. PubMed ID: 27019195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and characterization of colon-specific drug delivery system containing paracetamol microsponges.
    Jain V; Singh R
    Arch Pharm Res; 2011 May; 34(5):733-40. PubMed ID: 21656358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol.
    Obeidat WM; Nokhodchi A; Alkhatib H
    AAPS PharmSciTech; 2015 Oct; 16(5):1169-79. PubMed ID: 25724162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.